Yasushi Omuro
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment 8
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 16
- Pancreatic and Hepatic Oncology Research 9
- HER2/EGFR in Cancer Research 8
- Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes 21
- Cancer Research top 2%
-
- Lymphoma Diagnosis and Treatment 11
-
- Multiple and Secondary Primary Cancers 7
-
- Chronic Lymphocytic Leukemia Research 5
Yasushi Omuro
53 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Gastroenterology 1.3k
- Oncology 4.0k
- Pulmonary and Respiratory Medicine 4.0k
- Cancer Research 771
- Radiology, Nuclear Medicine and Imaging 961
Countries citing papers authored by Yasushi Omuro
This map shows the geographic impact of Yasushi Omuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Omuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Omuro more than expected).
Fields of papers citing papers by Yasushi Omuro
This network shows the impact of papers produced by Yasushi Omuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Omuro. The network helps show where Yasushi Omuro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasushi Omuro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2020 | 2 | |
| 3 | 2020 | 30 | |
| 4 | 2019 | 13 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 19 | |
| 7 | 2018 | 52 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 6 | |
| 10 | 2016 | 119 | |
| 11 | 2014 | 5 | |
| 12 | Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Studybreakdown → | 2014 | 474 |
| 13 | 2013 | 1 | |
| 14 | 2012 | 20 | |
| 15 | 2011 | 4 | |
| 16 | [A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]. | 2009 | 6 |
| 17 | 2003 | 21 | |
| 18 | 1999 | 86 | |
| 19 | 1998 | 17 | |
| 20 | 1998 | 17 |
About Yasushi Omuro
Yasushi Omuro is a scholar working on Gastroenterology, Oncology and Genetics, having authored 56 papers that have together received 6.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (21 papers), Colorectal Cancer Treatments and Studies (16 papers), Lymphoma Diagnosis and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), HER2/EGFR in Cancer Research (8 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Multiple and Secondary Primary Cancers (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Gastroenterology (1.3k citations), Oncology (4.0k citations) and Pulmonary and Respiratory Medicine (4.0k citations). Yasushi Omuro has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Taroh Satoh, Atsushi Ohtsu, Hyun Cheol Chung, Yung‐Jue Bang, Akira Sawaki, Yoon‐Koo Kang, Eric Van Cutsem, Julie Hill, A. Feyereislova and Giuseppe Aprile. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.